Skip to content

Evaluation of Use of Diagnostic AI for Lung Cancer in Practice

Evaluation of Use of Diagnostic AI for Lung Cancer in Practice

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03780582
Enrollment
15
Registered
2018-12-19
Start date
2018-12-14
Completion date
2019-12-15
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

This study investigates ways of improving radiologists performance of the classification of CT-scans as cancerous or non-cancerous. Participants interact with an AI to classify CT-scans under three different conditions.

Detailed description

The three conditions are as follows: probabilistic classification, where the radiologist diagnoses scans using an AI cancer likelihood score; classification plus detection, where the radiologist see detecting lung nodules in addition to the AI's probabilistic classification score before making her own examination of the CT-scan; and classification with delayed detection, where the radiologist identifies regions of interest independently of the AI and then sees the AI's detected ROIs.

Interventions

BEHAVIORALAI-human interaction

Exploring what kinds of AI-human interaction improve radiologists detection accuracy.

Sponsors

Ensemble Group Holdings, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* The participant performs radiology screenings professionally

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Classification accuracyup to 4 months after initiation of evaluation of the test setThis compares radiologists' classifications with the ground truth in the tested cases.

Secondary

MeasureTime frameDescription
detection concordanceup to 4 months after initiation of evaluation of the test setEvaluation of concordance between radiologists in the tested cases in detection of lung nodules \> 4 mm

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026